Search

Your search keyword '"Adrovic A"' showing total 69 results

Search Constraints

Start Over You searched for: Author "Adrovic A" Remove constraint Author: "Adrovic A" Database OAIster Remove constraint Database: OAIster
69 results on '"Adrovic A"'

Search Results

1. Digitala verktyg i matematikundervisning : En kvalitativ studie om mellanstadielärares användning av digitala verktyg i matematikundervisningen

2. Digitala verktyg i matematikundervisning : En kvalitativ studie om mellanstadielärares användning av digitala verktyg i matematikundervisningen

3. Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis

4. Gender differences in juvenile systemic sclerosis patients : Results from the international juvenile scleroderma inception cohort

5. Application of CRISS score, revised CRISS score and RCID score in patients with Juvenile systemic sclerosis

6. Patient and physician reported outcomes of juvenile systemic sclerosis patients significantly improve over 24 months observation period in the juvenile systemic scleroderma inception cohort

7. Diffuse juvenile systemic sclerosis patients show distinct organ involvement, antibody pattern and have significantly more severe disease in the largest jSSc cohort of the world. Results from the juvenile scleroderma inception cohort

8. Is decreased body mass index-2 z score or less correlating with an organ involvement pattern? Results from the juvenile scleroderma inception cohort

9. Begreppsuppfattning i matematik hos andraspråkselever

10. Diffuse juvenile systemic sclerosis patients show distinct organ involvement, antibody pattern and have significantly more severe disease in the largest jSSc cohort of the world. Results from the juvenile scleroderma inception cohort

11. Is decreased body mass index-2 z score or less correlating with an organ involvement pattern? Results from the juvenile scleroderma inception cohort

12. Patient and physician reported outcomes of juvenile systemic sclerosis patients significantly improve over 24 months observation period in the juvenile systemic scleroderma inception cohort

13. Application of CRISS score, revised CRISS score and RCID score in patients with Juvenile systemic sclerosis

14. Ultra-stable Silver Nanoplates: Efficient and Versatile Colorimetric Reporters for Dipstick Assays

15. Begreppsuppfattning i matematik hos andraspråkselever

16. Assessment of the transition of care from pediatric to adult rheumatology in a tertiary center

17. Diffuse juvenile systemic sclerosis patients show distinct organ involvement and have more severe disease in the largest jSSc cohort of the world. Results from the the juvenile scleroderma inception cohort

18. Juvenile systemic sclerosis treatment practices in an international cohort and comparison to recent SHARE consensus guidelines

19. Patient and physician reported outcomes of juvenile systemic sclerosis patients significantly improve over 12 months observation period in the juvenile systemic scleroderma inception cohort

20. Clinical characteristics of juvenile onset systemic sclerosis patients from the juvenile scleroderma inception cohort compared to adult age juvenile-onset patients from EUSTAR. Are these differences suggesting risk for mortality?

21. Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis

22. Diffuse juvenile systemic sclerosis patients show distinct organ involvement and have more severe disease in the largest jSSc cohort of the world. Results from the the juvenile scleroderma inception cohort

23. Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort

24. Juvenile systemic sclerosis treatment practices in an international cohort and comparison to recent SHARE consensus guidelines

25. Clinical characteristics of juvenile onset systemic sclerosis patients from the juvenile scleroderma inception cohort compared to adult age juvenile-onset patients from EUSTAR. Are these differences suggesting risk for mortality?

26. Patient and physician reported outcomes of juvenile systemic sclerosis patients significantly improve over 12 months observation period in the juvenile systemic scleroderma inception cohort

27. Juvenile systemic sclerosis (jSSc) patients with overlap characteristics do not have mild disease.Results from thejSSc inception cohort

28. Patients with juvenile systemic sclerosis have a distinct pattern of organ involvement. Results from thejuvenile systemic sclerosis inception cohort

29. Juvenile systemic sclerosis (jSSc) patients with overlap characteristics do not have mild disease.Results from thejSSc inception cohort

30. Patients with juvenile systemic sclerosis have a distinct pattern of organ involvement. Results from thejuvenile systemic sclerosis inception cohort

31. Is there a difference in presentation of female and male patients with juvenile systemic scleroderma?

32. Update from the juvenile scleroderma Inception Cohort

33. After 24 months observation period patient reported outcomes improved significantly in the juvenile Scleroderma Inceptions Cohort

34. Is there a difference in presentation of female and male patients with juvenile systemic scleroderma?

35. Do Raynaud phenomenon negative juvenile systemic scleroderma patients have a different pattern of organ involvement as Raynaud phenomenon positive patients?

36. Update from the juvenile scleroderma Inception Cohort

37. After 24 months observation period patient reported outcomes improved significantly in the juvenile Scleroderma Inceptions Cohort

38. Do Raynaud phenomenon negative juvenile systemic scleroderma patients have a different pattern of organ involvement as Raynaud phenomenon positive patients?

39. Update from the Juvenile Scleroderma Inception Cohort

40. Livet med en påse på magen : Upplevelser av att leva med en tarmstomi

41. Livet med en påse på magen : Upplevelser av att leva med en tarmstomi

42. Update on the juvenile systemic Sclerosis Inception Cohort Project. Characteristics of the first 97 Patients at first Assessment. www.juvenile-scleroderma.com

43. Is there a Difference in the clinical Presentation of juvenile Systemic Scleroderma Patients according the Age of onset: Results from the juvenile Scleroderma Inception Cohort www.juvenile-scleroderma.com

44. Is there a Difference in the Presentation of male and female Patients with diffuse subtype of juvenile systemic Sclerosis? Results from the juvenile Scleroderma Inception Cohort www.juvenile-scleroderma.com

45. Is there a Difference in the clinical Presentation of juvenile Systemic Scleroderma Patients according the Age of onset: Results from the juvenile Scleroderma Inception Cohort www.juvenile-scleroderma.com

46. Is there a Difference in the Presentation of male and female Patients with diffuse subtype of juvenile systemic Sclerosis? Results from the juvenile Scleroderma Inception Cohort www.juvenile-scleroderma.com

47. Update on the juvenile systemic Sclerosis Inception Cohort Project. Characteristics of the first 97 Patients at first Assessment. www.juvenile-scleroderma.com

48. Is there a difference in the presentation of male and female patients with juvenile systemic sclerosis? Results from the juvenile scleroderma inception cohort (www.juvenilescleroderma.com)

49. Trustication costs- En studie av förtroende och efterlevnad i en franchisekedja

50. Update on the juvenile systemic sclerosis inception cohort project (www.juvenilescleroderma.com). Characteristics of the first 74 patients at first assessment

Catalog

Books, media, physical & digital resources